Navigation Links
BMP Sunstone Reports Third Quarter 2008 Financial Results
Date:11/10/2008

- Reports Continued Improvement to Revenue, Operating and Profit

Performance -

-Company Reiterates Full Year 2008 Guidance-

PLYMOUTH MEETING, Pa., Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced its financial results for the third quarter ended September 30, 2008. During the quarter, BMP Sunstone successfully completed the acquisition of 63.3% of Rongheng, a pharmaceutical distribution company in Shanghai. Financial results reported below include the results of Rongheng beginning from July 4, 2008.

Financial Highlights as of September 30, 2008:

-- Record third quarter revenues were $30.5 million, a 240% increase from

$9.0 million in the third quarter of 2007.

-- Non-GAAP operating income, as defined below, was $3.5 million for the

quarter, improving from a loss of $1.5 million in the prior year

period.

Non-GAAP operating income for the nine-month period was $7.1 million.

-- Non-GAAP net income, as defined below, was $1.9 million for the quarter

and $3.5 million for the nine-month period.

-- Non-GAAP EPS was $0.05 for the quarter and $0.09 for the nine-month

period.

-- Non-GAAP operating income, net income, and earnings per share exclude

stock based compensation expense, amortization related to acquisitions,

and amortization of debt discount and issuance cost.

Please refer to the financial reconciliations provided in this news release for a reconciliation of GAAP results to non-GAAP results for the three and nine months periods ended September 30, 2008 and 2007.

Ta
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
4. BMP Sunstone Reports Second Quarter 2008 Financial Results
5. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
6. BMP Sunstone Announces Participation in September Investor Conference
7. BMP Sunstone Announces Participation in November Investor Conferences
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. QMed, Inc. Reports July Medicare SNP Enrollments
10. Phlo Affiliate Reports Expanded Coverage to Oregon Border
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...TY,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHea...t,GenomicHealth,sExecutiveChairman,willpresentatth...rkCityonTuesday,December1,2009at10:00a.m.ET. ,,...epresentation,visittheInvestorRelationssectionofGe...th.com .Pleaseconnecttothewebsiteatleast15minutesp...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the glo...hina,s patent office is now the world,s leading pr...ry. China trailed Japan,s patent office, the World...e United States Patent and Trademark Office (USPTO...2005, WIPO in 2006, and exceeded Japan for the fir...
(Date:11/23/2009)... You can think of it as origami very high-tech o...is have developed a technique for fabricating thre...es from thin films by coupling photolithography an...actions. , The films, only a few microns thick, o...ith thicker pieces of the same material. , "This ...
(Date:11/23/2009)...LLAGE,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBioPha...AQhasestablishedNovember27,2009astheex-dividenddat...ultingfromthesecuritizationtransactioncompletedonN...09toallstockholdersofrecordontherecorddate,Decembe...thedividendat$1.67pershareofcommonstockforpurposes...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...wswire-Asia-FirstCall/ -- China,Biologic Products,... or the,"Company"), one of the leading plasma-base...c of China ("PRC"), today announced that one of it...ill be listed in the National Torch,Plan of China....xecuted in 1988, by China,s,Ministry of Science an...
...ire-Asia-FirstCall/ -- Shengtai,Pharmaceutical, In...Company"),a leading manufacturer and distributor o...cts in China, today reported financial results for...31, 2008. , "Sales of our glucose products inc... September quarter," said Mr. Qingtai Liu, Shengta...
...ogies announces the launch of its new informative ...interactive e-book designed to introduce the gener...ying biotechnologies behind the clinical developme...ly targeted, genetic medicine that has been valida...Genetics, 2007), Rexin-G is designed to seek-out a...
Other Biology Technology:China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 2China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 3Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 2Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 3Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 4Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 5Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 6Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 7Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 8Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 9Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 10Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 11Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial 2
(Date:11/23/2009)...research presents strong evidence that the "synerg...or traffic-related pollution and indoor endotoxin ...he other exposure alone. , Environmental healt...College of Medicine have shown that children expos...s and indoor endotoxin during early life are six t...
(Date:11/23/2009)...ember 23, 2009 - The time of day matters to forest...per produced by a research team led by Professor M...,s vice-principal for research and colleagues in t...t. George campus. , Capitalizing on their prev... the research team examined how poplar trees use t...
(Date:11/23/2009)... Current research suggests that a common oral bac...ated report by Nichols et al, "Unique Lipids from ...TLR2 Ligands Capable of Enhancing Autoimmunity," a... Journal of Pathology . , Multiple sclerosis (MS...rain and spinal cord, affects nearly 1 in 700 peop...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 50906 1All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 50906 2Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 1Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 2Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 3Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 4Jazz Pharmaceuticals Completes 247 Million Private Placement 50902 1Jazz Pharmaceuticals Completes 247 Million Private Placement 50902 2
...aren Beemon has been awarded the third annual Retr...eque and a crystal trophy and is interviewed in an...l Retrovirology. She is Professor and Chair of the... I am very honored to receive the 2007 Retrovirolo...e Retrovirology community. It is gratifying that t...
...selaer Polytechnic Institute have developed a new ...rous proteins such as anthrax toxin, and render th... lends itself to the creation of new antibacterial...f germs, and also holds promise for new methods of... , Scientists have long been interested in wrappi...
...rons is a hallmark of many neurodegenerative disea...ell biology and regenerative medicine offer novel ... This week in the online open-access journal PLoS ...jeshwar Awatramani, and Dr. Ronald McKay show that...le in the birth and death of dopamine neurons in t...
Other Biology News:Karen Beemon wins the 2007 Retrovirology Prize 2Using carbon nanotubes to seek and destroy anthrax toxin and other harmful proteins 2
Rabbit Anti-NMDA NR2B, phospho (Tyr1336) Polyclonal Antibody, Unconjugated from Novus Biologicals
MTT Reagent A from CHEMICON
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
PIP Strips from Echelon Biosciences Inc.
Biology Products: